For people older than 12, Israel has ordered 100,000 units of Paxlovid, a Pfizer antiviral COVID 19 pill. Israeli Prime Minister Naftali Bennett agreed to the deal over the phone with Pfizer CEO Albert Bourla, who is in charge of the company.
Pfizer says the drug pill, named Paxlovid, cuts the risk of hospitalization and death by up to 90%, as Hamodia reported.
People who have a high risk of severe COVID-19 could soon get the medication. The CDC is also expected to quickly give its seal of approval, allowing Paxlovid to reach the market early.
The FDA has approved the pill for people 12 and older with mild to moderate COVID. People who take it are most likely to prevent being hospitalized or die. The agency said patients need to take the pills as soon as possible within five days infected by the first symptoms.
Experts say that even though the first antiviral pills for COVID-19 seemed to protect people at risk of getting very sick, Pfizer’s or Merck’s new medications may not be safe for everyone.
Paxlovid is an antiviral cocktail made by Pfizer. One of the two drugs in the cocktail could have very bad or even fatal interactions with many common medications, such as statins, blood thinners, and some antidepressants. The FDA doesn’t recommend Paxlovid for people with very bad kidney or liver disease.
In addition, the FDA has limited the use of the medication to adults and only when other treatments are not available or are not “clinically appropriate” due to concerns about the possible side effects.
Putting Paxlovid with other drugs that also break down with the CYP3A enzyme could make them more toxic because the ritonavir component could make them even more dangerous.